CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands		Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss).	Non-Controlling Interest	Total
Balance at beginning of period at Dec. 31, 2021	[1]	$ 345	$ 60,628	$ (251,725)	$ 12,018	$ 2,736	$ (175,998)
Balance at beginning of period (in shares) at Dec. 31, 2021	[1]	34,523
Net income (loss)				(10,589)		65	(10,524)
Other comprehensive income (loss)					(7,294)		(7,294)
Equity-based compensation		$ 3	476				479
Equity-based compensation (in shares)		333
Net share settlement of equity awards			(477)				(477)
Accumulating preferred dividends				(13,882)			(13,882)
Balance at end of period at Jun. 30, 2022	[1]	$ 348	60,627	(276,196)	4,724	2,801	(207,696)
Balance at end of period (in shares) at Jun. 30, 2022	[1]	34,856
Balance at beginning of period at Mar. 31, 2022		$ 348	60,319	(263,338)	7,158	2,907	(192,606)
Balance at beginning of period (in shares) at Mar. 31, 2022		34,856
Net income (loss)				(5,713)		(106)	(5,819)
Other comprehensive income (loss)					(2,434)		(2,434)
Equity-based compensation			308				308
Accumulating preferred dividends				(7,145)			(7,145)
Balance at end of period at Jun. 30, 2022	[1]	$ 348	60,627	(276,196)	4,724	2,801	(207,696)
Balance at end of period (in shares) at Jun. 30, 2022	[1]	34,856
Balance at beginning of period at Dec. 31, 2022		$ 750	342,664	(328,042)	(6,103)	2,460	11,729
Balance at beginning of period (in shares) at Dec. 31, 2022		75,020
Net income (loss)				(31,152)		15	(31,137)
Issuance of common shares related to acquisitions		$ 2	444				446
Issuance of common shares related to acquisitions (in shares)		40
Issuance of common shares related to Public Warrant exercise		$ 2	3,142				3,144
Issuance of common shares related to Public Warrant exercise (in shares)		229
Issuance of common shares related to stock options exercised		$ 1	62				63
Issuance of common shares related to stock options exercised (in shares)		6
Issuance of common shares related to conversion of Series A Convertible Preferred Shares		$ 1	253				254
Issuance of common shares related to conversion of Series A Convertible Preferred Shares (in shares)		22
Issuance of common shares related to purchase of non-controlling interest		$ 1	474				(2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares)		100
Issuance of common shares related to purchase of non-controlling interest						(2,475)
Accretion of Series A Convertible Preferred Shares			(341)				(341)
Other comprehensive income (loss)					1,564		1,564
Equity-based compensation		$ 3	3,854				3,857
Equity-based compensation (in shares)		311
Net share settlement of equity awards			(1,841)				(1,841)
Balance at end of period at Jun. 30, 2023		$ 760	348,711	(359,194)	(4,539)		(14,262)
Balance at end of period (in shares) at Jun. 30, 2023		75,728
Balance at beginning of period at Mar. 31, 2023		$ 759	345,840	(332,383)	(3,881)	2,475	12,810
Balance at beginning of period (in shares) at Mar. 31, 2023		75,628
Net income (loss)				(26,811)			(26,811)
Issuance of common shares related to purchase of non-controlling interest		$ 1	474				(2,000)
Issuance of common shares related to purchase of non-controlling interest (in shares)		100
Issuance of common shares related to purchase of non-controlling interest						$ (2,475)
Accretion of Series A Convertible Preferred Shares			87				87
Other comprehensive income (loss)					(658)		(658)
Equity-based compensation			2,310				2,310
Balance at end of period at Jun. 30, 2023		$ 760	$ 348,711	$ (359,194)	$ (4,539)		$ (14,262)
Balance at end of period (in shares) at Jun. 30, 2023		75,728

[1] (1) Retroactively adjusted the three and six months ended June 30, 2022 for the de-SPAC merger transaction as described in Note 4